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During viral infection, RIG-I-like receptors (RLRs) are activated upon dephosphorylation by the phosphatase
PP1, resulting in type I interferon production. In this issue, Davis et al. (2014) and Mesman et al. (2014) show
that measles virus inhibits this antiviral response by targeting PP1 and thus preventing RLR dephosphoryla-
tion and activation.Foreign RNAs are recognized by the
innate Toll-like receptor 3 (TLR3) in
phago-endosomes and by RIG-I-like re-
ceptors (RLR), RIG-I and MDA5, in the
cytoplasm (Figure 1). RLRs in infected
cells sense viral RNA and its replicative
products and trigger the activation of
the adaptor MAVS and subsequently the
transcription factor IRF-3. These events
lead to the production of type I interferon
(IFN), which in turn induces antiviral genes
and abrogates viral replication. A large
body of growing research provides a
detailed understanding of the unique fea-
tures of IRF-3- and IFN-inducible genes in
blocking virus replication through various
innate immune mechanisms. Despite
these sophisticated antiviral responses,
viruses have evolved strategies to circum-
vent the host antiviral IFN system.
As one example, the paramyxovirus
measles virus (MV) encodes the V and
C genes, which abrogates host innate
defense responses. The products of the
V and C genes are generated through
alternative reading frames or RNA editing
of the P protein-encoded region. The P
protein is critical for MV replication, while
the V and C proteins are accessory pro-
teins dispensable for assembling MV
particles, but have an important role in
suppressing the host IFN-inducing
pathway. In particular, the V protein has
been shown to antagonize IFN induction.
The mechanism whereby the V protein
MV supports viral propagation has been
proposed in earlier reports by Childs
et al. (2009) and Ikegame et al. (2010). A
major target of the MV-V protein is the
cytoplasmic DEAD/box helicase, MDA5.
The V protein of MV physically interacts
with MDA5, but the mechanism by which
the V protein interferes with MDA5 activity
to prevent type I IFN induction remainsunclear. Recent crystal-structure analysis
suggested that MV-V protein unfolds
MDA5 and binds a structural motif within
MDA5 that is normally buried in the heli-
case fold. This leads to disruption of the
MDA5 ATP-hydrolysis site and hinders
MDA5 activation.
In this issue, a pair of papers examine
how MV disrupts MDA5 and RIG-I activity
and show that activation of these RLRs
can be prevented by two different mecha-
nisms. Gack and colleagues (Davis et al.,
2014) use a series of biochemical studies
to show that the V protein inhibits MDA5
by preventing the removal of an inhibitory
phosphorylation mark. In a previous
report, the authors demonstrated that
MDA5 signaling is suppressed by con-
stitutive phosphorylation (Wies et al.,
2013). Dephosphorylation by the phos-
phatase PP1 is an essential step leading
to the unfolding and activation of MDA5.
In the current study, Gack and colleagues
present evidence that V protein forms
a complex with PP1a/g and serves as
a substrate for dephosphorylation by
PP1, which competitively prevents PP1-
mediated dephosphorylation of MDA5
(Figure 1).
This scenario requires that MDA5 be
constitutively suppressed by phospho-
rylation via the action of an unknown
kinase; however, how this initial modi-
fication of MDA5 occurs has not been
investigated. Additionally, as the main
conclusions regarding V protein-medi-
ated inhibition of MDA5 were largely
drawn using epithelial cell lines (Davis
et al., 2014), despite the fact that dendritic
cells (DCs) are the initial target during MV
infection, it will be important to determine
whether MV-V dephosphorylation by PP1
regulates MDA5 activation and type I IFN
production in MV-infected patients.Cell Host & MicIn a related study, Geijtenbeek and
colleagues (Mesman et al., 2014) show
that MV infection can also target PP1 in
DCs via a different mechanism. They
find that MV binding to the cell surface
lectin DC-SIGN signals the activation of
the kinase Raf-1, which leads to the inhi-
bition of phosphatase PP1 (Figure 1).
Raf-1 activation is known to facilitate
association of the phosphatase inhibitor
I-1 with GADD34-PP1 phosphatase holo-
enzymes, thereby inhibiting its phos-
phatase activity (Figure 1). This in turn,
antagonizes the IFN-induced antiviral
response, as the activation of both RIG-I
and MDA5 by PP1-dependent dephos-
phorylation is inhibited. Literature has
revealed that DC-SIGN may not act as
an entry receptor, but rather plays a role
in the attachment of MV (de Witte et al.,
2006). The current study further endowed
a function of DC-SIGN in controlling the
PP1 phosphatase function through Raf-1
signaling.
These reports present pathways
through which MV modulates antiviral
response of infected cells to promote
virus propagation. Myeloid-derived cells
like DCs are among the first cells that
become infected via the viral entry recep-
tors CD150 (for wild-type MV strains) and,
to a lesser extent, CD46 (vaccine strains).
These myeloid lineages encompass dif-
ferent cell subsets that express lineage-
specific surface molecules. According to
a recent report by Takaki et al. (2014),
DC subsets exhibit different susceptibility
to MV infection in a mouse model. Such
distinct features may be the result of
the activation of different antiviral path-
ways, namely the TLR/MyD88 pathway
in CD4+ T cells and plasmacytoid DCs
(pDCs) as opposed to the MAVS path-
way in mouse bone marrow-derived DCsrobe 16, July 9, 2014 ª2014 Elsevier Inc. 1
Figure 1. Measles Virus Subverts PP1-Mediated Dephosphorylation and Activation of RLRs
In response to viral infection, PP1 dephosphorylates MDA5 (right) and RIG-I (left) to induce their RNA-
sensing activity, ultimately resulting in type I IFN production. However, measles virus (MV) subverts this
response using two approaches. The MV-V protein acts as a competitive substrate for PP1 to block acti-
vation of MDA5. Additionally, the virus binds to the surface molecule DC-SIGN on dendritic cells and in-
duces the activation of the Raf-1 kinase. Raf-1 phosphorylates the phosphatase inhibitor I-1, resulting in
its association with GADD34-PP1 phosphatase holoenzymes and inhibition of their phosphatase activity.
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Previews(BMDCs). Although many reports have
emphasized an important role of the
RIG-I/MDA5-MAVS pathway in type I
IFN production in MV-infected cells,
such findings highlight the possibility
that susceptibility to MV infection may
vary depending on the type of human
DC subset targeted by the virus, since
each cell type activates its own unique
type I IFN induction pathway in response
to viral infection. MV infection studies
using monkeys will be a way to test the
compatibility of these studies on mouse
DC subsets with human DCs.
In addition to the role of MV-V protein in
targeting PP1 to preventMDA5 activation,
MV-V has also been shown to block NF-
kB activation by binding to the subunit
p65 RelA (Schuhmann et al., 2011) and
also inhibits STAT1 signaling downstream
of the interferon-a/b receptor (IFNAR).
The V protein also promotes MV replica-
tion by inhibiting the MAVS pathway or
possibly other unknown pathways. There-
fore, MV-V appears to regulate innate
immune responses in a complex fashion.
Human epithelial cells express an MV
entry receptor, Nectin4, and MDA5 and
RIG-I participate in MV RNA recognition2 Cell Host & Microbe 16, July 9, 2014 ª2014in this cell type. These results infer that
the above IFN-regulatory mechanisms,
other than the DC-SIGN-V protein axis,
may participate in regulating IRF-3 and
IFN induction in epithelial cells. It is
notable that V protein only minimally
blocks dephosphorylation of RIG-I under
the conditions where dephosphorylation
of MDA5 is blocked by MV-V in epithelial
cells (Davis et al., 2014). Hence, it remains
to be clarified whether the inhibition of
MDA5 dephosphorylation by V protein is
important in in vivo MV infection.
Another highlight from these studies
(Mesman et al., 2014) is that the virus is
regulating DCs via an interaction with
molecules expressed on the cell surface.
Other molecules expressed on the DC
surface such as CD46 (MCP) or CD150
(SLAM) can, respectively, transmit signals
that lead to autophagy or regulate B cell
activation. These molecules might influ-
ence DC-specific functions. In fact,
immune suppression is a characteristic
feature of MV infection, which may be in
part due to the failure of DC functions.
Aside from antagonizing the IFN-inducing
antiviral response of dsRNA, MDA5 has
also been reported to be associated withElsevier Inc.secondary responses, including T lym-
phocyte proliferation and NK cell activa-
tion in response to poly(I:C) (Wang et al.,
2010; Ebihara et al., 2010). In short, MV
may interfere with the functions of DC in
an early phase to further circumvent the
host antiviral IFN system.
As exemplified in these studies, viruses
have various strategies to escape IFN
attack. The present results elucidate
mechanisms by which the MAVS path-
way is regulated in paramyxovirus infec-
tion. The fact that MV employs multiple
strategies to inhibit RLR sensing and
activation further underscores the impor-
tance of IFN as an antiviral defense.ACKNOWLEDGMENTS
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